Valsts: Jaunzēlande
Valoda: angļu
Klimata pārmaiņas: Medsafe (Medicines Safety Authority)
Podophyllotoxin 0.15%{relative}
GlaxoSmithKline NZ Limited
Podophyllotoxin 0.15% w/w
0.15% w/w
Topical cream
Active: Podophyllotoxin 0.15%{relative} Excipient: Butylated hydroxyanisole Cetyl alcohol Emulsifying wax Isopropyl myristate Liquid paraffin Medium-chain triglycerides Methyl hydroxybenzoate Phosphoric acid Propyl hydroxybenzoate Purified water Sorbic acid Stearyl alcohol
Tube, aluminium, with HDPE screw cap, 5 g
Prescription
Prescription
Analytecon SA
For the topical treatment of external condylomata acuminata (anogenital warts).
Package - Contents - Shelf Life: Tube, aluminium, with HDPE screw cap - 5 g - 36 months from date of manufacture stored at or below 30°C - Tube, aluminium, with HDPE screw cap - 10 g - 36 months from date of manufacture stored at or below 30°C
2000-01-19
WARTEC CREAM ® 1 WARTEC CREAM ® _0.15% w/v podophyllotoxin _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Wartec Cream. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have benefits and risks. Your doctor has weighed the benefits of you using Wartec Cream against the risks they expect it may have for you. IF YOU HAVE ANY CONCERNS ABOUT THIS MEDICINE, ASK YOUR DOCTOR. KEEP THIS LEAFLET WITH YOUR MEDICINE. You may need to read it again. WHAT WARTEC CREAM IS USED FOR Wartec Cream contains podophyllotoxin, a plant extract that has antiwart properties. It works by destroying the skin of the wart. Wartec Cream is used on the skin to treat warts that are found in the external genital region (penis or vulva) or around the anus. It should not be used to treat warts that are found inside the anus or urinary canals of the penis or the vulva. These types of warts are commonly referred to as anogenital or venereal warts. They are caused by the Human Papilloma Virus (HPV). Up to half of sexually active adults are infected with HPV but only a small percentage will show outward signs of the virus. Anogenital warts are usually soft and skin coloured with a fleshy appearance. They are contagious and infection can occur through direct skin-to-skin contact. In adults, infection commonly occurs through sexual contact. Anogenital warts generally appear about 3 months after infection occurs; however they may not show themselves for over a year. Wartec Cream is not addictive. Wartec Cream is only available with a doctor's prescription. BEFORE YOU USE WARTEC CREAM DO NOT USE WARTEC Izlasiet visu dokumentu
NEW ZEALAND DATA SHEET WARTEC ® CREAM Podophyllotoxin 0.15% w/w PRESENTATION Wartec Cream contains podophyllotoxin 0.15% w/w in a white cream base for topical application. INDICATIONS Wartec Cream is indicated for the topical treatment of external condylomata acuminata (anogenital warts). DOSAGE AND ADMINISTRATION Wartec Cream is for topical application only. The affected area should be thoroughly washed with soap and water, and dried prior to application. Using a fingerstall or disposable glove, the cream is applied twice daily morning and evening (every 12 hours) for 3 consecutive days and then withheld for the next 4 consecutive days, using only enough cream to just cover each wart. Hands should be washed thoroughly after application. Application to the surrounding normal tissue should be avoided. Residual warts should be treated with further courses of twice daily applications for three days at weekly intervals, if necessary for a total of 4 weeks of treatment. Where lesions are greater than 4cm², it is recommended that treatment takes place under the direct supervision of medical staff. 1 There is a possibility of relapse following treatment and in the event that this does occur, alternative treatment may need to be considered. RENAL IMPAIRMENT No dosage adjustment is necessary. As there is very limited percutaneous absorption of podophyllotoxin with the recommended dosage, renal impairment is not expected to result in systemic exposure of clinical significance. HEPATIC IMPAIRMENT No dosage adjustment is necessary. As there is very limited percutaneous absorption of podophyllotoxin with the recommended dosage, hepatic impairment is not expected to result in systemic exposure of clinical significance. CONTRAINDICATIONS Do not use: − on open or bleeding wounds (e.g. following surgical procedures) − in children − if there is hypersensitivity to Izlasiet visu dokumentu